We are live on ! Find out more
GMVD

G Medical Innovations Holdings Ltd. Ordinary Shares

Delisted

GMVD was delisted on the 23rd of August, 2023.

9 hedge funds and large institutions have $1.51M invested in G Medical Innovations Holdings Ltd. Ordinary Shares in 2023 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

594% more capital invested

Capital invested by funds: $217K → $1.51M (+$1.29M)

100% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 3

50% more funds holding

Funds holding: 69 (+3)

Holders
9
Holders Change
+3
Holders Change %
+50%
% of All Funds
0.14%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
6
Increased
Reduced
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
SM
1
Sabby Management
Florida
$1.23M +$3.87M +1,350,000 New
PCM
2
Perkins Capital Management
Minnesota
$182K +$573K +200,000 New
Barclays
3
Barclays
United Kingdom
$51K +$161K +56,001 New
WAM
4
Warberg Asset Management
Illinois
$22.8K +$71.7K +25,000 New
RP
5
Regal Partners
Australia
$13.8K +$43.6K +15,211 New
CS
6
Clear Street
New York
$4.48K +$14.1K +4,925 New
Macquarie Group
7
Macquarie Group
Australia
$2.66K
HWM
8
HighMark Wealth Management
Minnesota
$43
HI
9
Harbour Investments
Wisconsin
$18
JP Morgan Chase
10
JP Morgan Chase
New York
-$196K -60,164 Closed
UBS Group
11
UBS Group
Switzerland
-$7.19K -2,193 Closed
Bank of America
12
Bank of America
North Carolina
-$4.07K -1,240 Closed

GMVD Hedge Fund Activity: Q1 2023 in Review

9 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in G Medical Innovations Holdings Ltd. Ordinary Shares (GMVD) for Q1 2023, worth a combined $1.51M — up 594% from $217K a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new GMVD positions and 3 closed out — a net gain of 3 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Sabby Management, opening a new position worth an estimated $3.87M. The largest seller was JP Morgan Chase, exiting entirely with an estimated $196K sold.

  • 9 institutional investors held G Medical Innovations Holdings Ltd. Ordinary Shares (GMVD) as of Q1 2023, up from 6 in Q4 2022.
  • Funds reported $1.51M of G Medical Innovations Holdings Ltd. Ordinary Shares stock for Q1 2023, up 594% quarter-over-quarter.
  • 6 funds opened new G Medical Innovations Holdings Ltd. Ordinary Shares positions in Q1 2023 and 3 closed out, a net change of +3 holders.
  • The largest G Medical Innovations Holdings Ltd. Ordinary Shares buyer in Q1 2023 was Sabby Management, an estimated $3.87M added.
  • The largest G Medical Innovations Holdings Ltd. Ordinary Shares seller in Q1 2023 was JP Morgan Chase, an estimated $196K sold.

Based on aggregated 13F filings for Q1 2023.